Ryan Merkow to Survival Rate
This is a "connection" page, showing publications Ryan Merkow has written about Survival Rate.
Connection Strength
0.698
-
Assessment of intermediate-term mortality following pancreatectomy for cancer. J Natl Cancer Inst. 2025 Jan 01; 117(1):49-57.
Score: 0.178
-
Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy. HPB (Oxford). 2020 02; 22(2):249-257.
Score: 0.122
-
Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome. Ann Surg Oncol. 2017 Nov; 24(12):3658-3666.
Score: 0.107
-
Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals. Ann Surg Oncol. 2012 Feb; 19(2):357-64.
Score: 0.070
-
American College of Surgeons survival calculator for biliary tract cancers: using machine learning to individualize predictions. Surgery. 2025 Feb; 178:108919.
Score: 0.044
-
Association of Hospital Volume With Quality Care Outcomes Following Minor and Major Hepatectomy for Primary Liver Cancer. J Surg Oncol. 2024 Oct; 130(5):1033-1041.
Score: 0.044
-
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection. Ann Surg Oncol. 2020 Mar; 27(3):909-918.
Score: 0.031
-
National practice patterns of completion lymph node dissection for sentinel node-positive melanoma. J Surg Oncol. 2018 Sep; 118(3):493-500.
Score: 0.029
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.019
-
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol. 2012 Nov; 19(12):3659-67.
Score: 0.019
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013 Feb; 20(2):362-70.
Score: 0.019
-
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.
Score: 0.017